Literature DB >> 2427340

Evidence for distinct epitopes on human IgG with T cell proliferative and suppressor function.

C N Baxevanis, C D Ioannides, G J Reclos, M Papamichail.   

Abstract

The Fc or pFc' fragments of the human IgG were demonstrated to exert different effects on murine T lymphocyte subsets. Thus, murine lymph node (LN) T cells were specifically induced to proliferate in vitro to pFc' after priming in vivo. This proliferation could be inhibited, either by depleting the responding LN population of macrophages, or by monoclonal antibodies specific for responder haplotype Ia antigenic determinants. Priming in vivo and subsequent restimulation in vitro with Fc resulted in the activation of a suppressor T cell subpopulation which, in an antigen-specific manner, could highly suppress proliferative responses. T cell subset isolation showed that the pFc'-specific proliferation was performed by Lyt-1+2- cells whereas the suppressor Fc-specific cells were of Lyt-1-2+ phenotype. Our data demonstrate that distinct epitopes on the human gamma chain induce either Ir gene-restricted T cell proliferation (pFc' fragment) or T cell suppressor function (Fc fragment).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427340     DOI: 10.1002/eji.1830160824

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes".

Authors:  Anne S De Groot; Leonard Moise; Julie A McMurry; Erik Wambre; Laurence Van Overtvelt; Philippe Moingeon; David W Scott; William Martin
Journal:  Blood       Date:  2008-07-25       Impact factor: 22.113

Review 2.  Immune suppression genes.

Authors:  D B Oliveira; N A Mitchison
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

Review 3.  Tolerogenic properties of the Fc portion of IgG and its relevance to the treatment and management of hemophilia

Authors:  Richard S Blumberg; David Lillicrap
Journal:  Blood       Date:  2018-03-27       Impact factor: 22.113

4.  Potential application of tregitopes as immunomodulating agents in multiple sclerosis.

Authors:  Wassim Elyaman; Samia J Khoury; David W Scott; Anne S De Groot
Journal:  Neurol Res Int       Date:  2011-09-15

Review 5.  Tregitope peptides: the active pharmaceutical ingredient of IVIG?

Authors:  Anne S De Groot; Leslie Cousens; Federico Mingozzi; William Martin
Journal:  Clin Dev Immunol       Date:  2013-12-25

Review 6.  From IgG Fusion Proteins to Engineered-Specific Human Regulatory T Cells: A Life of Tolerance.

Authors:  David W Scott
Journal:  Front Immunol       Date:  2017-11-13       Impact factor: 7.561

Review 7.  In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity.

Authors:  Leslie P Cousens; Nader Najafian; Federico Mingozzi; Wassim Elyaman; Bruce Mazer; Leonard Moise; Timothy J Messitt; Yan Su; Mohamed Sayegh; Katherine High; Samia J Khoury; David W Scott; Anne S De Groot
Journal:  J Clin Immunol       Date:  2012-09-02       Impact factor: 8.317

Review 8.  Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics.

Authors:  Anne S De Groot; Frances Terry; Leslie Cousens; William Martin
Journal:  Expert Rev Clin Pharmacol       Date:  2013-11       Impact factor: 5.045

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.